Find Federal Grants
Health Resources and Services Administration · HRSA-22-106
Notice of Intent to Publish a Funding Opportunity Announcement for Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
National Institutes of Health · NOT-MD-21-007
Impact of Technology and Digital Media (TDM) Exposure/Usage on Child and Adolescent Development (P01 Clinical Trial Optional)
National Institutes of Health · RFA-HD-22-009
National Institutes of Health · RFA-HD-22-005
Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional)
National Institutes of Health · RFA-CA-21-056
Limited Competition: Continued Development of the Gabriella Miller Kids First Pediatric Data Resource Center (U2C Clinical Trial Not Allowed)
National Institutes of Health · RFA-RM-21-014
National Institutes of Health · RFA-HD-22-007
National Institutes of Health · RFA-HD-22-008
Ryan White HIV/AIDS Program Part B AIDS Drug Assistance Program Training and Technical Assistance
Health Resources and Services Administration · HRSA-22-025
National Institutes of Health · PAR-21-282
National Institutes of Health · RFA-AA-21-016
National Institutes of Health · RFA-AA-21-017
NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
National Institutes of Health · PAR-21-306
National Institutes of Health · PAR-21-315
National Institutes of Health · PAR-21-314
Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
National Institutes of Health · PAR-21-313
Ethiopia USAID-Addis Ababa · 72066320BMA00001-2
Deciphering Immune-CNS interactions in people living with HIV on Anti-Retroviral therapy (R01 Clinical Trial Optional)
National Institutes of Health · RFA-MH-21-250
Deciphering Immune-CNS interactions in HIV utilizing in-vitro and in-vivo model systems (R21 Clinical Trial Not Allowed)
National Institutes of Health · RFA-MH-21-251
Selectively Target Technology Development to Understand How Changes or Dysfunction at the Capillary, Arterioles, and Small Lymphatic Vessels Level Can Have Long-term Impact on AD/ADRD (R01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-22-026